Lachey Jennifer 4
4 · Keros Therapeutics, Inc. · Filed Jun 14, 2022
Insider Transaction Report
Form 4
Lachey Jennifer
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2022-06-14$0.30/sh+9,400$2,820→ 95,100 total - Exercise/Conversion
Employee Stock Option (right to buy)
2022-06-14−9,400→ 56,705 totalExercise: $0.30Exp: 2028-03-25→ Common Stock (9,400 underlying)
Footnotes (1)
- [F1]Immediately exercisable.